Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adjuvants, Immunologic | 17 | 2022 | 954 | 3.250 |
Why?
|
Toll-Like Receptor 7 | 6 | 2022 | 179 | 2.520 |
Why?
|
Toll-Like Receptor 8 | 7 | 2018 | 92 | 2.300 |
Why?
|
Vaccines | 10 | 2022 | 719 | 1.960 |
Why?
|
Viral Vaccines | 2 | 2022 | 629 | 1.220 |
Why?
|
Dendritic Cells | 11 | 2020 | 2726 | 1.160 |
Why?
|
Whooping Cough | 2 | 2022 | 80 | 1.070 |
Why?
|
Aluminum Hydroxide | 2 | 2022 | 59 | 0.950 |
Why?
|
Vaccination | 9 | 2022 | 2864 | 0.940 |
Why?
|
Hemagglutinins | 1 | 2022 | 104 | 0.920 |
Why?
|
Fasciola hepatica | 5 | 2013 | 14 | 0.850 |
Why?
|
Flagellin | 2 | 2020 | 129 | 0.820 |
Why?
|
Toll-Like Receptor 5 | 1 | 2020 | 39 | 0.780 |
Why?
|
Quinolines | 4 | 2017 | 737 | 0.700 |
Why?
|
Imidazoles | 6 | 2017 | 1268 | 0.670 |
Why?
|
Toll-Like Receptors | 5 | 2018 | 594 | 0.660 |
Why?
|
BCG Vaccine | 2 | 2018 | 354 | 0.660 |
Why?
|
Drug Compounding | 1 | 2018 | 245 | 0.640 |
Why?
|
Antigens, Helminth | 4 | 2013 | 61 | 0.630 |
Why?
|
Cues | 1 | 2022 | 845 | 0.630 |
Why?
|
Monocytes | 6 | 2020 | 2660 | 0.590 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 465 | 0.590 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 981 | 0.580 |
Why?
|
Vaccines, Conjugate | 1 | 2017 | 327 | 0.560 |
Why?
|
Genetic Engineering | 1 | 2020 | 953 | 0.520 |
Why?
|
Cytokines | 14 | 2018 | 7189 | 0.500 |
Why?
|
Pneumococcal Vaccines | 1 | 2017 | 429 | 0.470 |
Why?
|
Th2 Cells | 3 | 2016 | 1054 | 0.440 |
Why?
|
Pertussis Vaccine | 2 | 2022 | 42 | 0.420 |
Why?
|
Ascaris lumbricoides | 1 | 2010 | 12 | 0.420 |
Why?
|
Benzazepines | 1 | 2013 | 326 | 0.410 |
Why?
|
Pentoxifylline | 3 | 2018 | 54 | 0.380 |
Why?
|
Drug Discovery | 1 | 2018 | 1066 | 0.380 |
Why?
|
Body Fluids | 1 | 2010 | 325 | 0.360 |
Why?
|
Immune System | 1 | 2014 | 806 | 0.350 |
Why?
|
Leukocytes | 2 | 2015 | 2095 | 0.340 |
Why?
|
Antibodies, Viral | 3 | 2022 | 2930 | 0.310 |
Why?
|
Immunity, Innate | 7 | 2022 | 2937 | 0.310 |
Why?
|
Vaccines, Acellular | 2 | 2022 | 12 | 0.290 |
Why?
|
Th1 Cells | 3 | 2016 | 1082 | 0.270 |
Why?
|
Nanoparticles | 1 | 2017 | 2048 | 0.270 |
Why?
|
Mice, Inbred BALB C | 6 | 2022 | 6684 | 0.270 |
Why?
|
Aging | 4 | 2018 | 8358 | 0.260 |
Why?
|
Animals, Newborn | 3 | 2020 | 2877 | 0.260 |
Why?
|
Mice | 13 | 2022 | 80876 | 0.250 |
Why?
|
Phenotype | 2 | 2020 | 16306 | 0.250 |
Why?
|
Infant, Newborn | 15 | 2020 | 24433 | 0.250 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2022 | 46 | 0.240 |
Why?
|
Inflammasomes | 2 | 2018 | 420 | 0.240 |
Why?
|
Cells, Cultured | 7 | 2020 | 20170 | 0.230 |
Why?
|
Animals | 21 | 2022 | 170486 | 0.220 |
Why?
|
Mannans | 1 | 2022 | 67 | 0.220 |
Why?
|
T-Lymphocyte Subsets | 2 | 2013 | 1924 | 0.220 |
Why?
|
Lung | 2 | 2022 | 9706 | 0.220 |
Why?
|
Fascioliasis | 2 | 2012 | 13 | 0.220 |
Why?
|
Immunomodulation | 2 | 2017 | 540 | 0.210 |
Why?
|
Lipopolysaccharides | 2 | 2017 | 2264 | 0.210 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2016 | 741 | 0.210 |
Why?
|
Immunization | 2 | 2022 | 1273 | 0.200 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 629 | 0.200 |
Why?
|
Mice, Inbred C57BL | 8 | 2022 | 22989 | 0.190 |
Why?
|
Interleukin-12 | 1 | 2022 | 597 | 0.190 |
Why?
|
Fentanyl | 1 | 2022 | 392 | 0.190 |
Why?
|
Caspase 1 | 3 | 2018 | 218 | 0.180 |
Why?
|
Virulence Factors, Bordetella | 1 | 2018 | 157 | 0.180 |
Why?
|
Fetal Blood | 4 | 2018 | 1334 | 0.180 |
Why?
|
Candida albicans | 1 | 2022 | 372 | 0.180 |
Why?
|
Administration, Intranasal | 1 | 2020 | 444 | 0.180 |
Why?
|
Fimbriae Proteins | 1 | 2018 | 137 | 0.170 |
Why?
|
Gentamicins | 1 | 2018 | 262 | 0.170 |
Why?
|
Polymers | 2 | 2017 | 1672 | 0.170 |
Why?
|
Lectins, C-Type | 2 | 2022 | 617 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 2 | 2018 | 1805 | 0.160 |
Why?
|
Antigens, Viral | 1 | 2022 | 1153 | 0.160 |
Why?
|
Lipid A | 2 | 2016 | 67 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2022 | 650 | 0.160 |
Why?
|
Hepatitis B Vaccines | 1 | 2018 | 189 | 0.150 |
Why?
|
Lymph Nodes | 3 | 2022 | 3409 | 0.150 |
Why?
|
Immunity, Mucosal | 1 | 2020 | 485 | 0.150 |
Why?
|
Humans | 31 | 2022 | 708843 | 0.150 |
Why?
|
Biomimetics | 1 | 2017 | 168 | 0.140 |
Why?
|
Adaptive Immunity | 2 | 2020 | 704 | 0.140 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 1796 | 0.140 |
Why?
|
Vancomycin | 1 | 2018 | 496 | 0.140 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4861 | 0.140 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 250 | 0.140 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10362 | 0.120 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 225 | 0.120 |
Why?
|
Organophosphorus Compounds | 1 | 2014 | 222 | 0.120 |
Why?
|
Macaca mulatta | 2 | 2017 | 2427 | 0.120 |
Why?
|
Drug Design | 1 | 2018 | 1100 | 0.110 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1192 | 0.110 |
Why?
|
Antibody Formation | 1 | 2016 | 1419 | 0.110 |
Why?
|
Anti-Infective Agents | 2 | 2018 | 927 | 0.110 |
Why?
|
Mice, SCID | 1 | 2017 | 2835 | 0.100 |
Why?
|
RNA, Messenger | 3 | 2022 | 13314 | 0.100 |
Why?
|
Alum Compounds | 3 | 2016 | 36 | 0.100 |
Why?
|
Child | 4 | 2022 | 73636 | 0.100 |
Why?
|
Leukocytes, Mononuclear | 2 | 2018 | 1719 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2012 | 591 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2016 | 1482 | 0.100 |
Why?
|
Drug Delivery Systems | 2 | 2020 | 2277 | 0.100 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1693 | 0.100 |
Why?
|
Infant | 4 | 2022 | 34261 | 0.090 |
Why?
|
Plasma | 1 | 2013 | 573 | 0.090 |
Why?
|
Homeostasis | 1 | 2020 | 3334 | 0.090 |
Why?
|
Immunologic Memory | 1 | 2016 | 1391 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2018 | 1321 | 0.090 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 1829 | 0.090 |
Why?
|
Zymosan | 1 | 2008 | 131 | 0.080 |
Why?
|
Immunity | 1 | 2014 | 957 | 0.080 |
Why?
|
Poly I-C | 1 | 2008 | 110 | 0.080 |
Why?
|
Ligands | 2 | 2022 | 3297 | 0.080 |
Why?
|
Cell Movement | 1 | 2020 | 5489 | 0.080 |
Why?
|
Phagocytosis | 2 | 2010 | 1594 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4658 | 0.080 |
Why?
|
Signal Transduction | 2 | 2018 | 23950 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1948 | 0.080 |
Why?
|
HEK293 Cells | 2 | 2015 | 4310 | 0.080 |
Why?
|
Adenosine | 1 | 2012 | 842 | 0.080 |
Why?
|
Polyethylene Glycols | 1 | 2012 | 1198 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3878 | 0.080 |
Why?
|
Proteome | 1 | 2016 | 1767 | 0.070 |
Why?
|
Lymphocyte Activation | 3 | 2016 | 5908 | 0.070 |
Why?
|
Thiazoles | 1 | 2013 | 1510 | 0.070 |
Why?
|
Malaria, Falciparum | 1 | 2013 | 941 | 0.070 |
Why?
|
Adult | 14 | 2022 | 211041 | 0.070 |
Why?
|
Blotting, Western | 2 | 2012 | 5456 | 0.070 |
Why?
|
Mast Cells | 1 | 2013 | 1601 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4383 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1482 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6530 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2009 | 894 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9907 | 0.060 |
Why?
|
Proteomics | 1 | 2016 | 3244 | 0.060 |
Why?
|
Plasmodium falciparum | 1 | 2013 | 1620 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2012 | 1578 | 0.060 |
Why?
|
Transcription Factor RelB | 1 | 2022 | 31 | 0.060 |
Why?
|
Aged | 4 | 2022 | 161488 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2020 | 1908 | 0.060 |
Why?
|
Pandemics | 1 | 2022 | 7089 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2013 | 6127 | 0.050 |
Why?
|
beta-Glucans | 1 | 2022 | 126 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 472 | 0.050 |
Why?
|
Antigens, CD | 2 | 2009 | 4169 | 0.050 |
Why?
|
Pediatrics | 1 | 2015 | 3554 | 0.050 |
Why?
|
Solubility | 1 | 2022 | 1156 | 0.050 |
Why?
|
Female | 11 | 2022 | 375205 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2022 | 1170 | 0.050 |
Why?
|
Bordetella pertussis | 1 | 2018 | 42 | 0.050 |
Why?
|
Paranasal Sinuses | 1 | 2022 | 270 | 0.050 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2018 | 42 | 0.040 |
Why?
|
NF-kappa B | 2 | 2018 | 2563 | 0.040 |
Why?
|
Colony Count, Microbial | 1 | 2018 | 334 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 667 | 0.040 |
Why?
|
Protein Subunits | 1 | 2022 | 1021 | 0.040 |
Why?
|
Term Birth | 1 | 2018 | 145 | 0.040 |
Why?
|
Azithromycin | 1 | 2018 | 180 | 0.040 |
Why?
|
Mass Spectrometry | 2 | 2016 | 2244 | 0.040 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2016 | 137 | 0.040 |
Why?
|
Dinoprostone | 1 | 2018 | 604 | 0.040 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2018 | 400 | 0.040 |
Why?
|
Epitopes | 1 | 2022 | 2646 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2016 | 209 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 294 | 0.030 |
Why?
|
Chemokines | 1 | 2018 | 954 | 0.030 |
Why?
|
DNA | 1 | 2008 | 7172 | 0.030 |
Why?
|
Drug Synergism | 1 | 2018 | 1875 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2020 | 3318 | 0.030 |
Why?
|
Octoxynol | 1 | 2012 | 81 | 0.030 |
Why?
|
Peritoneal Cavity | 1 | 2013 | 155 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2014 | 6850 | 0.030 |
Why?
|
STAT6 Transcription Factor | 1 | 2013 | 206 | 0.030 |
Why?
|
Male | 6 | 2022 | 349524 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 296 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2018 | 1446 | 0.030 |
Why?
|
Goats | 1 | 2012 | 190 | 0.030 |
Why?
|
Cell Degranulation | 1 | 2013 | 298 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 959 | 0.030 |
Why?
|
Helminth Proteins | 1 | 2012 | 178 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3879 | 0.030 |
Why?
|
Interleukins | 1 | 2016 | 799 | 0.030 |
Why?
|
Inflammation | 2 | 2022 | 10019 | 0.030 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2012 | 350 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2017 | 953 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2017 | 1213 | 0.030 |
Why?
|
Dexamethasone | 1 | 2018 | 1939 | 0.030 |
Why?
|
Nigeria | 1 | 2013 | 683 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 623 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 2203 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4226 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18712 | 0.020 |
Why?
|
Infant, Premature | 1 | 2018 | 1989 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2014 | 1303 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2244 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10803 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6562 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2009 | 291 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2012 | 2281 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4636 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2017 | 3179 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4422 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5784 | 0.020 |
Why?
|
Premature Birth | 1 | 2018 | 1498 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3308 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4353 | 0.020 |
Why?
|
Pregnancy | 2 | 2018 | 26832 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4466 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2596 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 11239 | 0.020 |
Why?
|
Shock, Septic | 1 | 2009 | 718 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 55940 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 14215 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12447 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 84718 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 18748 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11790 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 15274 | 0.010 |
Why?
|
Liver | 1 | 2013 | 7622 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9556 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 41038 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 61932 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18375 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 41081 | 0.010 |
Why?
|
Middle Aged | 1 | 2018 | 213752 | 0.000 |
Why?
|
Concepts
(225)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_